EPS: UK£0.40 (up from UK£0.26 in 1Q 2024). We've discovered 4 warning signs about GSK. View them for free. Revenue was in line with analyst estimates. Earnings per share (EPS) surpassed analyst ...

Alyson Hannigan, Ask2BSure spokesperson, actress, and mom, stars in an Ask2BSure campaign video to raise awareness about meningitis and vaccination amongst parents of teens and young adults.

GSK has shared the data behind its phase 3 liver disease win, revealing patients on linerixibat reported reductions in itching that began after two weeks and persisted through the 24-week primary ...

May 13 (Reuters) - India's GlaxoSmithKline Pharmaceuticals (GLAX.NS), opens new tab reported a higher fourth-quarter profit on Tuesday, led by steady demand for its generic drugs. The Indian unit ...

Recommendations supporting respiratory syncytial virus vaccines marketed by Pfizer (NYSE:PFE) and GSK (NYSE:GSK) made last month by an advisory panel to the CDC are under review from a top advisor ...

GSK has participated in an impressive $175 million Seres C financing for LifeMine led by Fidelity Management & Research Co, paying the company a $70 million license fee along with an undisclosed ...

The drugmaker's chief executive, Emma Walmsley noted this is the eighth time that GSK had headed the list, and comes after it pledged £1 billion ($1.2 billion) over the next decade to accelerate ...

GSK plc announced positive results from the GLISTEN phase III trial evaluating linerixibat, an investigational targeted inhibitor of the ileal bile acid transporter (IBAT), in adults with cholestatic ...

iTeos and GSK have decided to terminate the belrestotug development program, which could signal a major setback for the company's research efforts. The decision to terminate all belrestotug ...

GSK’s (LSE: GSK) share price is down 20% from its 15 May 12-month traded high of £18.19. This sort of a drop could indicate that a bargain-basement buying opportunity is to be had. Or it could flag ...

GSK plc announced data from across its respiratory portfolio will be presented in 43 abstracts, including four late-breaking submissions, at the 2025 American Thoracic Society (ATS) International ...